View results from the State of the Nation Report (January 2025) for individual NHS organisations (NHS Trusts and Local Health Boards) in Excel.

Display performance indicators from the State of the Nation Report (January 2025) for individual NHS organisations, and compare with other organisations' results.

In our first State of the Nation Report, we focus on the care received by patients diagnosed with oesophago-gastric cancer between April 2020 and March 2022 in England and Wales, and the outcomes of treatment. We also evaluate the care pathway followed by patients diagnosed with oesophageal high grade dysplasia in England.

A composite indicator that summarises the performance of OG cancer specialist centres in England and Wales, across a range of performance indicators published in the NOGCA January 2024 State of the Nation Report.

In our 14th Annual Report, we focus on the care received by patients diagnosed with oesophago-gastric cancer between April 2019 and March 2021 in England and Wales, and the outcomes of treatment. We also evaluate the care pathway followed by patients diagnosed with oesophageal high grade dysplasia in England.

A composite indicator that summarises the performance of OG cancer specialist centres in England and Wales, across a range of performance indicators published in the NOGCA 2022 Annual Report.

In our 13th Annual Report, we focus on the care received by patients diagnosed with oesophago-gastric cancer between April 2018 and March 2020 in England and Wales, and the outcomes of treatment. We also evaluate the care pathway followed by patients diagnosed with oesophageal high grade dysplasia in England.

A composite indicator that summarises the performance of OG cancer specialist centres in England and Wales, across a range of performance indicators published in the NOGCA 2021 Annual Report.

A composite indicator that summarises the performance of OG cancer specialist centres in England and Wales, across a range of performance indicators published in the NOGCA 2020 Annual Report.

In our 12th Annual Report, we focus on the care received by patients diagnosed with oesophago-gastric cancer between April 2017 and March 2019 in England and Wales, and the outcomes of treatment. We also evaluate the care pathway followed by patients diagnosed with oesophageal high grade dysplasia in England.